Thomas W. Gardner
Photo
Academic title Professor of Ophthalmology, and Cellular and Molecular Physiology
College College of Medicine
Campuses Penn State Milton S. Hershey Medical Center
Department Ophthalmology
Joint departments Cellular and Molecular Physiology
Graduate programs Integrative Biosciences
Physiology
Cell and Molecular Biology
Neuroscience
Email Phone FAX
  tgardner@psu.edu
  717 531 8783
  717 531 5475
Educational background
  M.D., Jefferson Medical College, 1979
Fellowship Training, Bascom Palmer Eye Institute, 1983-1984
Research interests
 

Study of Basic Mechanisms Which May Initiate Diabetic Retinopathy, with Particular Focus on Regulation of Tight Junction Proteins

Diabetic retinopathy is a leading cause of blindness. One of the characteristic features of diabetes is abnormal leakage of small blood vessels in the retina and kidney. Work in our laboratory is focused on the mechanisms of cellular injury in the retina which lead to retinopathy. Specifically, we are interested in the factors which increase or decrease tight junction protein expression.

The members of the Penn State Retina Research Group have found that diabetes reduces retinal vascular tight junction protein (occludin) expression coincident with increased vascular permeability and are now investigating the regulation of occludin expression in diabetic rats and in retinal endothelial cells in culture.

In addition we are studying changes in the neural retina in diabetes and have found apoptosis of inner retinal neurons that begins early in the course of diabetes and is reduced with insulin therapy. Investigations are now underway to explore the mechanism of retinal cell death in the retina.

Graphic
  Graphic
  ZO-1 tight junction protein in retinal endothelial cells.
Areas of expertise
 
Endothelium, VascularPOEMS Syndrome
Diabetic RetinopathyEndothelial Growth Factors
Scleral BucklingNeuroprotective Agents
ApoptosisIntraocular Pressure
AstrocytesRetina
Retinal NeovascularizationRetinal Degeneration
HexosaminesChoroid Diseases
Retinal DetachmentRetinal Diseases
Blood-Retinal BarrierDiabetes Mellitus
Diabetes Mellitus, ExperimentalDiabetes Mellitus, Type 1
Monitoring, IntraoperativeInsulin
HistamineGlial Fibrillary Acidic Protein
Tight Junctions1-Phosphatidylinositol 3-Kinase
Retinal VesselsMembrane Proteins
NeurogliaNeurons
Eye ProteinsPhosphoproteins
Capillary PermeabilityReceptor, Insulin
Signal TransductionProto-Oncogene Proteins
Cell Membrane PermeabilityHypoglycemic Agents
Ribosomal Protein S6 Kinases, 70-kDaStress, Mechanical
Histamine H1 AntagonistsVision Disorders
Scattering, RadiationWater
Nitric OxideAorta
AstemizoleReceptors, Histamine H1
LymphokinesBody Water
CarbazolesIndoles
CaspasesCytokines
InflammationMicroglia
MinocyclineDisease Models, Animal
Protein Kinase CVascular Endothelial Growth Factor A
Enzyme InhibitorsMaleimides
Insulin-Like Growth Factor IPlatelet-Derived Growth Factor
Retinal Ganglion CellsDiabetes Complications
Macular EdemaObesity
OphthalmologyPhysician's Practice Patterns
Publication author name
  Gardner TW
Select publications
  Nakamura M. Barber AJ. Antonetti DA. LaNoue KF. Robinson KA. Buse MG. Gardner TW. Excessive hexosamines block the neuroprotective effect of insulin and induce apoptosis in retinal neurons. 2001 Nov 23. J Biol Chem. 276(47):43748-55.
National Institute of Diabetes and Digestive and Kidney Diseases
National Eye Institute
Barber AJ. Lieth E. Khin SA. Antonetti DA. Buchanan AG. Gardner TW. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. 1998 Aug 15. J Clin Invest. 102(4):783-91.
National Eye Institute
Antonetti DA. Barber AJ. Hollinger LA. Wolpert EB. Gardner TW. Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors. 1999 Aug 13. J Biol Chem. 274(33):23463-7.
National Eye Institute
Antonetti DA. Barber AJ. Khin S. Lieth E. Tarbell JM. Gardner TW. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. 1998 Dec. Diabetes. 47(12):1953-9.
National Eye Institute
Gardner TW. Antonetti DA. Barber AJ. LaNoue KF. Levison SW. Diabetic retinopathy: more than meets the eye. 2002 Dec. Surv Ophthalmol. 47 Suppl 2:S253-62.
National Eye Institute

also ...
All publications